XML 40 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income taxes
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income taxes

Note 14. Income taxes

The components of our loss before income taxes were as follows:

 

 

Year ended December 31,

 

(in thousands)

 

2023

 

 

2022

 

 

2021

 

United States loss

 

$

(48,530

)

 

$

(98,462

)

 

$

(106,467

)

Foreign income (loss)

 

 

(2,098

)

 

 

(716

)

 

 

47

 

Total loss before income taxes

 

$

(50,628

)

 

$

(99,178

)

 

$

(106,420

)

 

The provisions for (benefits from) income taxes and the reasons for the differences between the provisions for and benefits from income taxes using the U.S. federal income tax rate were as follows:

 

 

Year ended December 31,

 

(in thousands)

 

2023

 

 

2022

 

 

2021

 

Current -

 

 

 

 

 

 

 

 

 

Federal

 

$

 

 

$

 

 

$

 

State

 

 

(350

)

 

 

204

 

 

 

196

 

Foreign

 

 

95

 

 

 

231

 

 

 

(27

)

 

 

 

(255

)

 

 

435

 

 

 

169

 

Deferred -

 

 

 

 

 

 

 

 

 

Federal

 

 

 

 

 

 

 

 

 

State

 

 

 

 

 

 

 

 

 

Foreign

 

 

(83

)

 

 

 

 

 

 

 

 

 

(83

)

 

 

 

 

 

 

Provisions for (benefits from) income taxes

 

$

(338

)

 

$

435

 

 

$

169

 

 

 

 

 

 

 

 

 

 

 

Federal income tax benefit at statutory rate

 

$

(10,632

)

 

$

(20,827

)

 

$

(22,348

)

State taxes, net of federal

 

 

(739

)

 

 

(1,035

)

 

 

(1,744

)

Research and experimentation tax credit

 

 

1,544

 

 

 

(2,811

)

 

 

(342

)

Change in valuation allowance

 

 

10,200

 

 

 

24,911

 

 

 

28,361

 

Stock compensation

 

 

1,218

 

 

 

(1,781

)

 

 

(6,863

)

Section 162m limitation on executive compensation

 

 

203

 

 

 

1,922

 

 

 

2,467

 

Deferred tax true ups

 

 

(1,500

)

 

 

(764

)

 

 

126

 

State payable true ups

 

 

(326

)

 

 

204

 

 

 

57

 

Permanent differences and other

 

 

(306

)

 

 

616

 

 

 

455

 

Provisions for (benefits from) income taxes

 

$

(338

)

 

$

435

 

 

$

169

 

The components of deferred tax assets and liabilities were as follows:

(in thousands)

 

December 31,
2023

 

 

December 31,
2022

 

Deferred tax assets:

 

 

 

 

 

 

Fixed assets and intangibles

 

$

44

 

 

$

5

 

Leases

 

 

348

 

 

 

255

 

Accrued expenses

 

 

5,590

 

 

 

4,887

 

Net operating loss carryforward

 

 

64,055

 

 

 

52,179

 

Stock options

 

 

2,475

 

 

 

3,528

 

R&D credit carryforward

 

 

1,886

 

 

 

3,431

 

Other

 

 

2,048

 

 

 

1,998

 

Subtotal

 

 

76,446

 

 

 

66,283

 

Less: valuation allowance

 

 

(75,858

)

 

 

(65,659

)

Total deferred tax assets

 

 

588

 

 

 

624

 

 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

 

Leases

 

 

(339

)

 

 

(243

)

Prepaid expenses

 

 

(166

)

 

 

(381

)

Total deferred tax liabilities

 

 

(505

)

 

 

(624

)

Net deferred tax asset (liability)

 

$

83

 

 

$

 

The net change in the total valuation allowance for the year ended December 31, 2023, was an increase of $10.2 million recorded through continuing operations. The net change in the total valuation allowance for the year ended December 31, 2022, was an increase of $24.9 million recorded through continuing operations. In assessing the realizability of deferred tax assets, we considered whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. We considered the scheduled reversal of deferred tax liabilities, carryback potential, projected future taxable income and tax planning strategies in making this assessment. After consideration of these factors and based upon the level of historical taxable losses, we believe it is more likely than not that the Company will not realize the benefits of these deductible differences at December 31, 2023.

We have federal net operating loss carryforwards of approximately $282.1 million at December 31, 2023. These loss carryforwards have an indefinite carryforward period. We also have state net operating loss carryforwards of approximately $95.0 million which begin to expire in 2034.

We have federal R&D credit carryforwards of approximately $2.4 million at December 31, 2023, which begin to expire in 2038.

Utilization of the Company's net operating loss carryforwards and other tax attributes to offset federal taxable income may be subject to annual limitation due to changes in ownership, pursuant to Internal Revenue Code Sections 382 and 383.

We are subject to U.S. federal income tax, as well as income tax in multiple state and foreign jurisdictions. The tax returns for years 2018 and beyond remain open for examination. As of December 31, 2023, the Company is not currently under audit by any taxing authority.

We account for uncertainty in taxes in accordance with authoritative guidance. Changes in our accruals for unrecognized tax benefits were as follows:

 

 

Year ended December 31,

 

(in thousands)

 

2023

 

 

2022

 

Balance at beginning of period

 

$

1,421

 

 

$

717

 

Increase for tax positions related to the current period

 

 

 

 

 

386

 

Increase for tax provisions related to prior periods

 

 

 

 

 

318

 

Decrease for tax positions related to prior periods

 

 

(382

)

 

 

 

Balance at end of period

 

$

1,039

 

 

$

1,421

 

The unrecognized tax benefits would not impact the effective tax rate if recognized due to the valuation allowance. We do not anticipate a significant increase or decrease over the next twelve months in the unrecognized tax benefits reported above. As of December 31, 2023, and 2022, we have not accrued any interest or penalties related to unrecognized tax benefits.